Drug Shortage Report for BREVICON 1/35 TABLETS (28-DAY PACK)
Report ID | 168162 |
Drug Identification Number | 02189062 |
Brand name | BREVICON 1/35 TABLETS (28-DAY PACK) |
Common or Proper name | Brevicon 28 |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | ETHINYL ESTRADIOL NORETHINDRONE |
Strength(s) | 0.035MG 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 28 DAYS PACK BLST |
ATC code | G03AA |
ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-10-17 |
Actual start date | |
Estimated end date | 2022-10-21 |
Actual end date | 2022-10-20 |
Shortage status | Resolved |
Updated date | 2022-10-21 |
Company comments | Available inventory is on preventative allocation. Other presentations available : BREVICON 1/0.035mg (21’S), BREVICON 0.5/0.035mg (21’s), BREVICON 0.5/0.035mg (28’s). |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2022-10-21 | French | Compare |
v6 | 2022-10-21 | English | Compare |
v5 | 2022-10-18 | English | Compare |
v4 | 2022-10-13 | French | Compare |
v3 | 2022-10-13 | English | Compare |
v2 | 2022-08-29 | French | Compare |
v1 | 2022-08-29 | English | Compare |
Showing 1 to 7 of 7